Rallybio (RLYB) Equity Ratio (2023 - 2025)
Rallybio's Equity Ratio history spans 3 years, with the latest figure at 0.93 for Q3 2025.
- For Q3 2025, Equity Ratio rose 3.93% year-over-year to 0.93; the TTM value through Sep 2025 reached 0.93, up 3.93%, while the annual FY2024 figure was 0.91, 1.43% down from the prior year.
- Equity Ratio for Q3 2025 was 0.93 at Rallybio, up from 0.91 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.96 in Q1 2023 and bottomed at 0.9 in Q3 2024.
- The 3-year median for Equity Ratio is 0.93 (2023), against an average of 0.93.
- The largest annual shift saw Equity Ratio decreased 3.39% in 2024 before it grew 3.93% in 2025.
- A 3-year view of Equity Ratio shows it stood at 0.92 in 2023, then fell by 1.43% to 0.91 in 2024, then increased by 2.91% to 0.93 in 2025.
- Per Business Quant, the three most recent readings for RLYB's Equity Ratio are 0.93 (Q3 2025), 0.91 (Q4 2024), and 0.9 (Q3 2024).